Publications found:
29
Sort by:
Antisense & RNAi Therapeutics Market Forecasts to 2034 – Global Analysis By Route of Administration (Subcutaneous Route, Intravenous Route, Pulmonary Delivery, Intrathecal Route, Intraperitoneal Injection and Other Routes of Administration), Indication (Autosomal Dominant Disease, Autosomal Recessive Disease, Chromosomal Disease and Other Indications), Technology, Application and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Antisense & RNAi Therapeutics Market is accounted for $2.39 billion in 2026 and is expected to reach $3.36 billion by 2034 growing at a CAGR of 13.0% during th...
May 2026
200 pages
mRNA Therapeutics Market Forecasts to 2034 – Global Analysis By Therapy Type (Prophylactic mRNA Therapeutics, and Therapeutic mRNA Therapeutics), mRNA Construct Type (Conventional Non-replicating mRNA, Self-amplifying mRNA, Circular mRNA, and Trans-amplifying mRNA), Delivery System, Application, End User, Distribution Channel, and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global mRNA Therapeutics Market is accounted for $13.0 billion in 2026 and is expected to reach $60.3 billion by 2034 growing at a CAGR of 21.1% during the forecast p...
May 2026
200 pages
Antisense Oligonucleotides Market - 2025-2033
US$ 2,999.00
The Antisense Oligonucleotides Market was valued at US$ 3,180.1 million in 2025 and is anticipated to reach US$ 5,286.96 million by 2033, at a CAGR of 0.065 from 2026 to 2032. The report delivers in-d...
April 2026
223 pages
Global mRNA Purification Equipment Market Growth 2026-2032
US$ 3,660.00
The global mRNA Purification Equipment market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. United States market fo...
April 2026
100 pages
Oligonucleotide Therapy Market - 2024-2033
US$ 2,999.00
The Oligonucleotide Therapy Market was valued at US$ 8.80 Billion in 2024 and is anticipated to reach US$ 40.16 Billion by 2033, at a CAGR of 0.186 from 2026 to 2032. The report delivers in-depth insi...
October 2025
200 pages
RNAi Therapeutics Market - 2024
US$ 2,999.00
The RNAi Therapeutics Market was valued at USD 2.60 billion in 2024 and is anticipated to reach by , at a CAGR of 0.146 from 2026 to 2032. The report delivers in-depth insights into key market dynamic...
September 2025
210 pages
Global RNA-based Therapies Market - 2024-2033
US$ 2,999.00
The Global RNA-based Therapies Market was valued at US$ 90.56 billion in 2024 and is anticipated to reach US$ 213.54billion by 2033, at a CAGR of 0.1 from 2026 to 2032. The report delivers in-depth in...
September 2025
243 pages
RNAi Technology Market - 2024-2033
US$ 2,999.00
The RNAi Technology Market was valued at US$ 2.75 Billion in 2024 and is anticipated to reach US$ 6.63 Billion by 2033, at a CAGR of 0.104 from 2026 to 2032. The report delivers in-depth insights into...
September 2025
207 pages
mRNA Vaccine and Therapeutics Market - 2024-2033
US$ 2,999.00
The mRNA Vaccine and Therapeutics Market was valued at US$ 46.32 Billion in 2024 and is anticipated to reach US$ 200.11 Billion by 2033, at a CAGR of 0.184 from 2026 to 2032. The report delivers in-de...
August 2025
217 pages
Nucleic Acid Therapeutics Market - 2024-2032
US$ 2,999.00
The Nucleic Acid Therapeutics Market was valued at US$ 5.64 billion in 2024 and is anticipated to reach US$ 14.42 billion by 2032, at a CAGR of 0.109 from 2026 to 2032. The report delivers in-depth in...
July 2025
219 pages
mRNA Vaccines Market 2026
US$ 2,999.00
The mRNA Vaccines Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growth...
March 2025
219 pages